Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Characteristics and Long-term Mortality in Patients with ST-Segment Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries (STE-MINOCA): A High Risk Cohort

作者:Odayme Quesada, Mehmet Yildiz, Timothy D. Henry, Brynn Okeson, Jenny Chambers, Ananya Shah, Larissa Stanberry, Lucas Volpenhein, Dalia Aziz, Rebekah Lantz, Cassady Palmer, Justin Ugwu, Muhammad Junaid Ahsan, Ross Garberich, Heather Rohm, Frank V. Aguirre, Santiago García, Scott W. Sharkey · 发表于:medRxiv · 年份:2023 · DOI:10.1101/2023.02.05.23285502 · 被引用次数:4 · 研究领域:Acute Myocardial Infarction Research、Coronary Interventions and Diagnostics、Cardiac Imaging and Diagnostics

Background: The prognosis of ST-segment elevation myocardial infarction with non-obstructive coronaries (STE-MINOCA) is largely unknown. Methods: The objective of this study is to evaluate the prevalence, characteristics, and 5-year mortality of patients with STE-MINOCA compared to STEMI with coronary artery obstruction (STEMI-Obstruction) using a multicenter cohort of consecutive STEMI patients at 3 regional Midwest STEMI programs from 2003 to 2020. STE-MINOCA was defined based on (1) coronary stenosis < 60% by visual estimation, (2) ischemia with elevated troponin, and (3) no alternative diagnosis. STE-MINOCA was further classified based on American Heart Association (AHA) definition as AHA STE-MINOCA and AHA STE-MINOCA Mimicker. Results: 8,566 STEMI patients, including 420 (4.9%) STE-MINOCA (26.9% AHA STE-MINOCA and 73.1% AHA STE-MINOCA Mimicker) were followed for a median of 7.1 years. Compared to STEMI-Obstruction, STE-MINOCA were younger, more often female, had fewer cardiovascular risk factors, and were less likely to be discharged on cardiac medications. At five years, mortality was higher in STE-MINOCA compared with STEMI-Obstruction (18% vs. 15%, p=0.033). In propensity score-matched analysis, STE-MINOCA had a 1.4-fold (95% CI: 1.04-1.89, p=0.028) higher risk of 5-year all-cause mortality compared with STEMI-Obstruction. Furthermore, 5-year mortality risk was significantly higher in AHA STE-MINOCA Mimicker (19% vs. 15%, p=0.043) but similar in AHA STE-MINOCA (17% vs...